HIV Infection
📧 Sign up to get email alerts when something new happens for HIV Infection.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2016-11-08FDA Approved: TIVICAY — Supplemental Application (ViiV Healthcare Company)
FDA approved a supplemental application for Tivicay (dolutegravir) submitted by ViiV Healthcare Company, authorizing changes to the product …
-
CLINICAL_TRIALS trial_result · 2016-11-08Clinical Trial Update: Evaluation of Three Strategies of Second-line Antiretroviral Treatment in Africa (Dakar - Bobo-Dioulasso - Yaoundé) [Phase 3]
Phase 3 clinical trial update evaluating three strategies of second-line antiretroviral treatment in Africa (Dakar, Bobo-Dioulasso, Yaoundé)…
-
CLINICAL_TRIALS trial_result · 2016-11-07Clinical Trial Update: A Study of Zidovudine in the Prevention of HIV Infection in Individuals Exposed to the Virus [NA]
This update reports on a completed clinical trial evaluating zidovudine (AZT) for preventing HIV infection in individuals exposed to the vir…
-
CLINICAL_TRIALS trial_result · 2016-11-07Clinical Trial Update: A Study of HIV in Newly Infected Individuals
A clinical trial studying HIV infection in individuals newly infected has completed.
-
FDA approval · 2016-11-04FDA Approved: SELZENTRY — Original Application (ViiV Healthcare Company)
FDA approves SELZENTRY (maraviroc) under the original application for treatment of HIV-1 infection.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2016-11-04FDA Approved: SELZENTRY — Supplemental Application (ViiV Healthcare Company)
FDA approved a supplemental application for SELZENTRY (maraviroc) submitted by ViiV Healthcare Company.
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Study Comparing the Efficacy and Safety of Once-Daily Fuzeon (Enfuvirtide) Dosing Versus the Currently Recommended Twice-Daily Dosing in Human Immunodeficiency Virus-Type 1 (HIV-1) Infected Patients [Phase 2]
Phase 2 study comparing once-daily dosing of Fuzeon (enfuvirtide) to the standard twice-daily regimen in HIV-1 infected patients has complet…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Study of Ritonavir-Boosted Invirase (Saquinavir) in Treatment-Naïve HIV-1 Infected Patients [Phase 1]
This Phase 1 trial evaluated ritonavir-boosted saquinavir in treatment-naive HIV-1 infected patients and has completed.
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: Observational Study on Predictors of Response to Invirase (Saquinavir) Treatment in Treatment-naïve Patients With HIV Infection
This completed observational study investigates predictors of response to saquinavir (Invirase) treatment in treatment-naïve people with HIV…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: An Observational Study of Induction Therapy With Fuzeon (Enfuvirtide) in Combination With Antiretroviral Drugs in Patients With HIV-1 Infection
This completed observational study evaluated induction therapy with Fuzeon (enfuvirtide) in combination with other antiretroviral drugs for …
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: QUALITE Study - A Study of Fuzeon (Enfuvirtide) in Treatment-Experienced Patients With Human Immunodeficiency Virus-1 (HIV-1) Infection [Phase 4]
The QUALITE study evaluated enfuvirtide (Fuzeon) in treatment-experienced HIV-1 patients in Phase 4, and the trial has completed.
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: Optimizing Integrated PMTCT Services in Rural North-Central Nigeria [NA]
A completed clinical trial evaluating integrated PMTCT services in rural North-Central Nigeria.
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Study of Enfuvirtide (Fuzeon) in Patients With Advanced Human Immunodeficiency Virus-1 (HIV-1) Infection [Phase 4]
Phase 4 clinical trial update for enfuvirtide (Fuzeon) in patients with advanced HIV-1 infection; study status completed.
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: Contingency Management in the Delivery of HAART to Drug Users in Chennai, India [Phase 2]
Phase 2 trial update on using contingency management to improve delivery/adherence of HAART to HIV patients who are intravenous drug users i…
-
CLINICAL_TRIALS trial_result · 2016-11-01Clinical Trial Update: Phase 3 Open-Label Study to Evaluate Switching From Optimized Stable Antiretroviral Regimens Containing Darunavir to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Fixed Dose Combination (FDC) Plus Darunavir (DRV) in Treatment Experienced HIV-1 Positive Adults [Phase 3]
Phase 3 open-label study evaluating switching from optimized darunavir-containing regimens to a fixed-dose combination of elvitegravir/cobic…
-
CLINICAL_TRIALS trial_result · 2016-11-01Clinical Trial Update: Compassionate Use of Ibalizumab for the Treatment of HIV Infection
This document provides an update on compassionate-use access to ibalizumab for HIV infection. It notes that the trial is no longer available…
-
CLINICAL_TRIALS research · 2016-11-01Clinical Trial Update: Collection of Blood Samples From SMART Study Participants for Future Genetic Studies
The SMART study will collect blood samples from participants for future genetic studies. This update communicates ongoing research activitie…
-
CLINICAL_TRIALS trial_result · 2016-10-31Clinical Trial Update: Evaluation of the Safety and Efficacy of Reformulated Raltegravir (MK-0518) 1200 mg Once Daily in Combination With TRUVADA™ in Human Immunodeficiency Virus (HIV)-1 Infected, Treatment-Naive Participants (MK-0518-292) [Phase 3]
Phase 3 MK-0518-292 evaluated the safety and efficacy of reformulated raltegravir 1200 mg once daily in combination with TRUVADA in treatmen…
-
CLINICAL_TRIALS trial_result · 2016-10-31Clinical Trial Update: A Study to Determine Safety and Efficacy of Dolutegravir/Abacavir/Lamivudine (DTG/ABC/3TC) in Human Immunodeficiency Virus (HIV)-1 Infected Antiretroviral Therapy (ART) Naïve Women (ARIA) [Phase 3]
Phase 3 trial evaluating DTG/ABC/3TC in ART-naïve HIV-infected women; study completed with results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-10-31Clinical Trial Update: A Treatment IND for Retrovir Brand Zidovudine (AZT) Therapy of Pediatric Patients With HIV Disease [NA]
A clinical trial update indicates the treatment IND study of Zidovudine (AZT) for pediatric HIV infection has completed under the NIAID spon…
-
CLINICAL_TRIALS trial_result · 2016-10-31Clinical Trial Update: The Effect of Acyclovir Treatment of the Herpes Simplex Virus (HSV) Infection on HIV Levels in the Blood [NA]
A completed clinical trial evaluated whether acyclovir treatment of herpes simplex virus infection affects HIV levels in the blood.
-
CLINICAL_TRIALS trial_result · 2016-10-31Clinical Trial Update: A Test of Behavioral Intervention for Women at High Risk for HIV Infection
This clinical trial evaluated a behavioral intervention to reduce HIV infection risk in women at high risk, and the study is completed.
-
CLINICAL_TRIALS withdrawal · 2016-10-28Clinical Trial Update: PEPI-TiDP23-C104 is a First in Human Study With a Single Dose Escalation Part and a Multiple Dosing Part for Compounds TMC589337 and TMC589354. [Phase 1]
A first-in-human Phase 1 trial of Tibotec compounds TMC589337 and TMC589354 (single-dose escalation and multiple-dosing parts) has been with…
-
CLINICAL_TRIALS trial_result · 2016-10-28Clinical Trial Update: Adherence & Health Outcome Differences Amongst HIV Infected Patients Prescribed HAART
A completed clinical trial update examining differences in adherence and health outcomes among HIV-infected patients on HAART.
-
CLINICAL_TRIALS trial_result · 2016-10-27Clinical Trial Update: Effect of Schistosomiasis Mansoni on HIV Susceptibility and Female Genital Immunology [Phase 4]
Phase 4 clinical trial completion update examining whether Schistosoma mansoni infection influences HIV susceptibility and female genital im…